Back to medications
Medication monograph

lebrikizumab

Monoclonal AntibodiesImmunomodulatorsInterleukin-13 Antagonist

Brands & formulations

Family members

EBGLYSS

Marketed
250 MGSUBCUTANEOUSSOLUTION[ "lebrikizumab" ]
Product monograph

EBGLYSS

Marketed
250 MGSUBCUTANEOUSSOLUTION[ "lebrikizumab" ]
Product monograph

Classification

Chemical class
Monoclonal Antibodies
Clinical class
Immunomodulators
Banks class
Interleukin-13 Antagonist